MFMariana Nobre Farias de Franca

Mariana Nobre Farias de Franca

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mariana Nobre Farias de Franca has a total of 47 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Spatio-temporal distribution of financial/economic violence in a northeastern state of Brazil

    by Erica Santos dos Reis, Rosália Elen Santos Ramos, Letícia Pereira Bezerra, Mariana Nobre Farias de Franca, João Henrique Oliveira Bonifacio, Gabriele Barbosa Santana, Laiza Santos Biano, Etjo Rodrigo Santana Nunes, Letícia de Souza Ramos, Aline Barreto Hora

    The Ministry of Health defines economic-financial violence (FEV) as destructive actions or omissions of the aggressor that affect the emotional health and survival of family members. Thus, the objective of this research was to analyze the spatio-temporal distribution of FEV in the state of Bahia, Northeastern Brazil. An ecological, time series study (2010-2018) was conducted, using spatio-temporal analysis tools. As a result, we observed that most cases of FEV occurred among women and the chances of the occurrence are higher in households, in adults and the elderly, in addition, there was an increasing trend of cases among males. We identified a heterogeneous distribution in the Bahian territory suggesting the inexistence of a distribution pattern of violence. However, in the spatial-temporal analysis high risk clusters were observed in the south-central region of the state. This work made it possible to identify areas of risk for the occurrence of AFV, especially in the south-central region of Bahia. Besides characterizing the victimized population, such as adults and the elderly being the most likely to suffer this type of violence.

  • Open Access

    Anti-inflammatory natural products modulate interleukins and their related signaling markers in inflammatory bowel disease: A systematic review

    by Gopalsamy Rajiv Gandhi, Thiruchenduran Mohana, Kumaraswamy Athesh, Varghese Edwin Hillary, Alan Bruno Silva Vasconcelos, Mariana Nobre Farias de Franca, Monalisa Martins Montalvão, Stanislaus Antony Ceasar, Gnanasekaran Jothi, Gurunagarajan Sridharan, et al.


  • Dynamics of SARS-CoV-2 seroprevalence during the first year of the COVID-19 pandemic in the Northeast region of Brazil

    by Adriano Antunes de Souza Araújo, Lucindo José Quintans-Júnior, Luana Heimfarth, Dulce Marta Schimieguel, Cristiane Bani Corrêa, Tatiana Rodrigues de Moura, Rafael Ciro Marques Cavalcante, Renata Grespan, Jullyana de Souza Siqueira Quintans, Danillo Menezes dos Santos, et al.

    In this household-based seroepidemiological survey, we analyzed the dynamics of SARS-CoV-2 seroprevalence during the first year of the COVID-19 pandemic in Sergipe State, Northeast Brazil, the poorest region of the country. A total of 16,547 individuals were tested using a rapid IgM−IgG antibody test and fluorescence immunoassay (FIA). Seroprevalence rates were presented according to age, sex, and geographic region. A comparative analysis was performed between the results obtained in July 2020 (peak of the first wave), August – November 2020 (end of the first wave), and February – March 2021 (beginning of the second wave). Seroprevalence rates in the three phases were estimated at 9.3% (95% CI 8.5–10.1), 12.0% (95% CI 11.2–12.9) and 15.4% (95% CI 14.5–16.4). At the end of the first wave, there was a rise in seroprevalence in the countryside (p < 0.001). At the beginning of the second wave, we found an increase in seroprevalence among women (p < 0.001), adults aged 20 to 59 years (p < 0.001), and the elderly (p < 0.001). In this phase, we found an increase in estimates both in metropolitan areas and in the countryside (p < 0.001). This study showed an increase in SARS-CoV-2 seroprevalence over the first year of the pandemic, with approximately one in six people having anti-SARS-CoV-2 antibodies at the beginning of the second wave of COVID-19. Furthermore, our results suggest a rapid spread of COVID-19 from metropolitan areas to the countryside during the first months of the pandemic.


  • Health functions and related molecular mechanisms of ellagitannin-derived urolithins

    by Gopalsamy Rajiv Gandhi, Poovathumkal James Antony, Stanislaus Antony Ceasar, Alan Bruno Silva Vasconcelos, Monalisa Martins Montalvão, Mariana Nobre Farias de Franca, Ayane de Sá Resende, Chelankara Suresh Sharanya, Yi Liu, Govindasamy Hariharan, et al.

    Ellagitannins are vital bioactive polyphenols that are widely distributed in a variety of plant-based foods. The main metabolites of ellagitannins are urolithins, and current research suggests that urolithins provide a variety of health benefits. This review focused on the role of the gut bacteria in the conversion of ellagitannins to urolithins. Based on the results of in vitro and in vivo studies, the health benefits of urolithins, including antioxidant, anti-inflammatory, anti-cancer, anti-obesity, anti-diabetic, anti-aging, cardiovascular protective, neuroprotective, kidney protective, and muscle mass protective effects, were thoroughly outlined, with a focus on their associated molecular mechanisms. Finally, we briefly commented on urolithins’ safety. Overall, urolithins’ diverse health benefits indicate the potential utilization of ellagitannins and urolithins in the creation of functional foods and nutraceuticals to treat and prevent some chronic diseases. Graphical Abstract